Iglesias Juan Fernando
Clinical trials sponsored by Iglesias Juan Fernando, explained in plain language.
-
Heart attack patients may soon ditch aspirin thanks to new stent and drug combo
Disease control Recruiting nowThis study tests if a newer, thinner stent (coated with a drug to prevent re-narrowing) plus a single, potent blood thinner (without aspirin) works as well as the standard two-drug therapy after a heart attack. The goal is to lower bleeding risk while still preventing future hear…
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Wrist access showdown: could a new artery route reduce heart procedure risks?
Knowledge-focused Recruiting nowThis study compares two ways to reach the heart's arteries during complex procedures like opening blocked vessels. It tests if using a smaller artery in the hand (distal radial) instead of the usual wrist artery (conventional radial) lowers the risk of artery blockage afterward. …
Phase: NA • Sponsor: IGLESIAS Juan Fernando • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC